Carlsmed, Inc. engages in the development of AI based technology solutions to the medical industry. The company is headquartered in Carlsbad, California. The company went IPO on 2025-07-23. Its aprevo technology platform offers solutions for the entire surgical workflow, including pre-operative AI-enabled, surgical planning; intra-operative advanced visualization to support precision placement of aprevo interbody implants, and post-operative data collection and insights intended to improve the digital surgical planning process. Its pre-operative planning software utilizes standard-of-care diagnostic imaging and AI-enabled algorithms to develop personalized digital surgical plans and to design aprevo interbody implants for each patient's pathology and vertebral bone topography. Additionally, the aprevo technology platform supports the collection of real-world, post-operative data to inform its digital surgical planning process. Its platform is commercially available in the United States and is indicated for use in lumbar interbody fusion procedures.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
12/31/2024
12/31/2023
Revenue
62
54
27
Revenue Growth (YoY)
--
100%
--
Cost of Revenue
16
7
3
Gross Profit
46
20
9
Selling, General & Admin
65
29
21
Research & Development
26
14
7
Operating Expenses
91
95
60
Other Non Operating Income (Expenses)
0
0
0
Pretax Income
-45
-48
-37
Income Tax Expense
--
--
--
Net Income
-46
-49
-37
Net Income Growth
--
32%
--
Shares Outstanding (Diluted)
21.08
26.51
26.51
Shares Change (YoY)
--
0%
--
EPS (Diluted)
-2.2
-1.87
-1.42
EPS Growth
--
31%
--
Free Cash Flow
-42
-51
-35
Free Cash Flow Per Share
--
--
--
Gross Margin
74.19%
37.03%
33.33%
Operating Margin
-72.58%
-88.88%
-137.03%
Profit Margin
-74.19%
-90.74%
-137.03%
Free Cash Flow Margin
-67.74%
-94.44%
-129.62%
EBITDA
-45
-48
-37
EBITDA Margin
-72.58%
-88.88%
-137.03%
D&A For EBITDA
0
0
0
EBIT
-45
-48
-37
EBIT Margin
-72.58%
-88.88%
-137.03%
Effective Tax Rate
--
--
--
Follow-Up Questions
What are Carlsmed Inc's key financial statements?
According to the latest financial statement (Form-10K), Carlsmed Inc has a total asset of $51, Net loss of $-49
What are the key financial ratios for CARL?
Carlsmed Inc's Current ratio is 1.96, has a Net margin is -90.74, sales per share of $2.03.
How is Carlsmed Inc's revenue broken down by segment or geography?
Carlsmed Inc largest revenue segment is Aprevo, at a revenue of 27,165,000 in the most earnings release.For geography, United States is the primary market for Carlsmed Inc, at a revenue of 27,165,000.
Is Carlsmed Inc profitable?
no, according to the latest financial statements, Carlsmed Inc has a net loss of $-49
Does Carlsmed Inc have any liabilities?
yes, Carlsmed Inc has liability of 26
How many outstanding shares for Carlsmed Inc?
Carlsmed Inc has a total outstanding shares of 26.51